Journey Of Excellence

Rubicon has come a long way as a globally recognized drug delivery company in a short span of 10 years

2010 – Present

• Rubicon licenses out Loratadine ODT to leading Pharma MNC
• Rubicon licenses out a complex SR Suspension to a leading generic company
• Rubicon successfully completes feasibility study of RubiCoat® for Big Pharma NCE project

2008 – 2009

• Approval from German Health Authority (BCS) for Analytics and Stability studies
• Commissioned state of the art cGMP manufacturing facility
• RubiODT® excipient licensed to Avantor, US (Formerly known as Mallinckrodt Baker Inc.) for worldwide commercialization
• Rubicon gets MAA for Requip Equivalent for EU Market

2004 – 2007

• Rubicon licenses out Vitamin C CR (RubiSRT®) for EU, CIS & other emerging markets
• First International patent granted
• Leading MNC launches Rubicon’s developed products in India
• Rubicon licenses first CR Product i.e. Metformin CR to a US Company

2000 – 2003

• Rubicon files its first International Patent
• Rubicon sets up a dedicated team for technology development
• Rubicon starts its operations with three scientists